ARTICLE | Company News
Navidea seeking EU approval for Lymphoseek
December 19, 2012 2:15 AM UTC
Navidea Biopharmaceuticals Inc. (NYSE-M:NAVB) submitted an MAA to EMA for Lymphoseek tilmanocept for use in intraoperative lymphatic imaging. Navidea said the MAA covers the use of Lymphoseek for gene...